BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug designation (ODD) to exidavnemab for the treatment ...

Across two cohorts, the Automated Imaging Differentiation for Parkinsonism (AIDP) machine learning model distinguished ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of ...

Lundbeck’ amlenetug receives Japanese orphan drug designation for treatment of multiple system atrophy: Denmark Tuesday, March 11, 2025, 11:00 Hrs [IST] H. Lundbeck A/S (Lundbec ...

Background Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of unknown etiology, manifesting as combination of parkinsonism, cerebellar syndrome and dysautonomia.

Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, today announced that it has secured ?9.

Donna is survived by her three sons, Craig (Kim) of Atlanta, David (Cheryl) and Michael (Karan) of Ringgold, seven ...

The 22nd Annual CurePSP Awareness and Memorial Walk will take place on March 29th at Mackle Park on Marco Island. The event ...

Accuity, a leading provider of technology-powered, physician-led clinical documentation review services, today announced that its solution residing at Microsoft Azure has once again earned certified ...

REM sleep behavior disorder is characterized by acting out dreams, which may include shouting, kicking and punching during sleep.

Cerebellar rhythm loss due to climbing fiber regression is a shared pathophysiology of motor deficits across cerebellar ataxias. Cerebellar ataxias are a group of genetic and non-genetic disorders ...